市場調查報告書
商品編碼
1471990
血管成形術球囊市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍:按類型、應用和最終用戶Angioplasty Balloons Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, and End User |
依據「2030 年血管成形球囊市場預測 - 全球分析 - 類型、應用、最終用戶和地理位置」的最新研究,2022 年市場估值為 27.1 億美元,預計到 2030 年將達到 36 億美元;預計2022年至2030年複合年成長率為3.6%。
血管成形術是一種用於拓寬狹窄或打開阻塞的冠狀動脈並恢復血流的技術。基於價值的護理注重成本效益和患者治療結果,正在改變醫療保健產業。與其他可用治療方法相比,血管成形術球囊的市場將受到這些設備提供更好的患者治療效果、降低血管重建率和更低成本的能力的影響。與傳統的手術方法相比,血管成形術球囊提供了一種侵入性較小的治療動脈阻塞的方法。
美洲 HEARTS 計劃由衛生部牽頭,當地利益相關者參與,並得到泛美衛生組織 (PAHO) 的技術合作。該計劃正在該地區 22 個國家的 1,400 多個衛生中心實施。到 2025 年,HEARTS 將成為美洲初級衛生保健中心血管風險管理的典範,其中包括高血壓、糖尿病和血脂異常等疾病。
此外,在歐洲,醫療保健公共支出的成長速度快於國內支出,但主要是在高收入國家。歐盟委員會的EU4Health 計劃、下一代復甦基金和Horizon Europe 研究基金提供了一個機會,透過實施歐盟行動計劃中確定的改善心血管健康的預防措施,解決心血管疾病的負擔並改善公民的心血管健康。該計劃涵蓋了整個患者旅程,從預防和早期檢測到獲得護理和治療,再到生活品質和功能狀態,考慮到數位化和創新在各個階段的重要作用。因此,增加醫療保健支出和政府主導的有關心臟健康的措施將為血管成形術球囊市場創造成長機會。
按類型分類,基於血管成形術球囊市場的見解
根據類型,血管成形術球囊市場分為普通球囊、藥物洗脫球囊、切割球囊和評分球囊。 2022 年,普通球囊細分市場佔據最大的血管成形球囊市場。在血管內治療中,藥物塗層球囊(DCB)(主要是紫杉醇塗層球囊)被更頻繁地使用,以改善血管成形術的低通暢性結果。在解決血液透析通路功能障礙時,從短期來看,使用藥物洗脫球囊可能比簡單的球囊血管成形術需要更少的再介入和相關的醫療費用。
按最終用戶,基於血管成形術球囊市場的見解
血管成形術球囊市場,依最終使用者、醫院、門診手術中心等分類。醫院細分市場在 2022 年佔據最大的血管成形球囊市場佔有率,並且由於住院時間要求最短和先進服務的可用性,預計 2022 年至 2030 年複合年成長率最高。此外,在門診手術中心進行的治療具有成本效益,這有助於降低總醫療費用。所有這些因素都促進了門診手術中心領域的成長。
世界心臟聯合會歐洲學會和世界衛生組織是在準備血管成形術球囊市場報告時提到的一些主要二手來源。
註 - 將為以下提到的地區/國家提供類似的分析
According to our latest study on " Angioplasty Balloons Market Forecast to 2030 - Global Analysis -Type, Application, End User, and Geography," the market was valued at US$ 2.71 billion in 2022 and is expected to reach US$ 3.60 billion by 2030; it is estimated to register a CAGR of 3.6% from 2022 to 2030.
An angioplasty is a technique used to widen narrowed or open clogged coronary arteries and restore blood flow. Value-based care, which focuses on cost-effectiveness and patient outcomes, is changing the healthcare sector. The market for angioplasty balloons will be influenced by the capacity of these devices to provide better patient outcomes, reduced revascularization rates, and lower costs compared to other available treatments. Compared to conventional surgical methods, angioplasty balloons provide a less invasive method of treating clogged arteries.
The initiative HEARTS in the Americas is led by the Ministries of Health with the participation of local stakeholders and the technical cooperation of the Pan American Health Organization (PAHO). The Initiative is being executed in more than 1,400 health centers in 22 nations across the region. By 2025, HEARTS will be the model for cardiovascular risk management, which includes diseases such as hypertension, diabetes, and dyslipidemia, in primary health care in the Americas.
Moreover, in Europe, public spending on healthcare has grown faster than domestic spending, but mainly in high-income countries. The European Commission's EU4Health program, the Next Generation Recovery Funds, and the Horizon Europe Research Funds offer an opportunity to address the burden of cardiovascular diseases and improve the cardiovascular health of citizens by implementing preventative measures identified in an EU Action Plan for better cardiovascular health. This plan covers the overall patient journey, from prevention and early detection to access to care and treatment to quality of life and functioning status, considering the vital role of digitization and innovation at all stages. Thus, increasing healthcare spending and government-led initiatives regarding heart health to create growth opportunity in angioplasty balloons market.
By Type, Angioplasty Balloons Market-Based Insights
Based on type, the angioplasty balloons market is segmented into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. The normal balloons segment held the largest angioplasty balloons market share in 2022. However, the drug eluting balloons segment is anticipated to register the highest CAGR during 2022-2030. In endovascular therapy, drug-coated balloons (DCB), primarily paclitaxel-coated balloons, are being utilized more frequently to improve the low patency results of angioplasty. When addressing hemodialysis access dysfunction, the use of drug-eluting balloons might, in the short run, require less reintervention and associated healthcare costs than simple balloon angioplasty.
By End User, Angioplasty Balloons Market-Based Insights
The angioplasty balloons market, by end user, hospitals, ambulatory surgery centers, and others. The hospitals segment held the largest angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022-2030, owing to the minimum hospital stay requirements and the availability of advanced services. In addition, treatments performed in ambulatory surgery centers are cost-effective, which helps cut down on total medical costs. All these factors contribute to the growth of the ambulatory surgery center segment.
European Society of World Heart Federation, and the World Health Organization, are a few of the major secondary sources referred to while preparing the report on the angioplasty balloons market.
Note - Similar analysis would be provided for below mentioned regions/countries
Note - Similar information would be provided for below list of companies